azd9742
Small moleculeexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT01030224)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- azd9742
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01275781 | Phase 1 | Jan 1, 2011 | AstraZeneca, IQVIA |
| NCT01154621 | Phase 1 | Jun 1, 2010 | AstraZeneca, Bio-Kinetic Clinical Applications |
| NCT01124760 | Phase 1 | May 1, 2010 | AstraZeneca, IQVIA |
| NCT01114152 | Phase 1 | Apr 1, 2010 | AstraZeneca, California Clinical Trials |
| NCT01064388 | Phase 1 | Feb 1, 2010 | AstraZeneca, IQVIA |
| NCT01030224 | Phase 1 | Nov 1, 2009 | AstraZeneca, IQVIA |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 6 | 6 | 1 | 2009 |
| IQVIA | For profit | 4 | 0 | 1 | 2009 |
| Bio-Kinetic Clinical Applications | For profit | 1 | 0 | 1 | 2010 |
| California Clinical Trials | For profit | 1 | 0 | 1 | 2010 |
4 organizations
Page 1 / 1